Antibody nanoparticles override immunological tolerance of tumors
Date | 16th, Jul 2019 |
---|---|
Source | Nanowerk - Nanotechnology Websites |
DESCRIPTION
Scientists have developed a tumor enzymatic microenvironment-activatable antibody nanoparticle for robust cancer immunotherapy.